维生素D与超重/肥胖人群组织特异性胰岛素敏感性的关系
本研究纳入92例BMI>25 kg/m²的成人,采用两步高胰岛素-正常血糖钳夹联合[6,6-2H2]-葡萄糖示踪评估组织特异性胰岛素敏感性,并检测血浆25(OH)D3、1,25(OH)2D3及腹部皮下脂肪组织VDR与CYP酶mRNA表达。结果显示BMI与血浆25(OH)D3呈负相关,血浆维生素D代谢物与组织特异性胰岛素敏感性无关,但皮下脂肪组织VDR mRNA表达与脂肪组织胰岛素敏感性呈负相关。
要点
- BMI与血浆25(OH)D3呈独立负相关,但与1,25(OH)2D3无关。
- 血浆25(OH)D3和1,25(OH)2D3均与组织特异性胰岛素敏感性无关。
- 皮下脂肪组织VDR mRNA表达与脂肪组织胰岛素敏感性呈负相关。
核心结论
- BMI与血浆25(OH)D3浓度呈负相关,但该关联不能由皮下脂肪组织VDR和CYP酶表达改变解释。
- 血浆维生素D代谢物与组织特异性胰岛素敏感性无关,而皮下脂肪组织VDR表达与脂肪组织胰岛素敏感性呈负相关。
研究设计与样本
- 纳入92例BMI>25 kg/m²的成人,采用两步高胰岛素-正常血糖钳夹联合[6,6-2H2]-葡萄糖示踪评估组织特异性胰岛素敏感性。
- 通过定量RT-PCR测定腹部皮下脂肪组织VDR及CYP酶mRNA表达,分析其与血浆维生素D代谢物及胰岛素敏感性的关联。
主要发现
- BMI与血浆25(OH)D3呈负相关(β=-0.274;P=0.011),与血浆1,25(OH)2D3无关联。
- 血浆25(OH)D3与皮下脂肪组织CYP酶或VDR表达无关。
- 血浆1,25(OH)2D3和25(OH)D3均与组织特异性胰岛素敏感性无关。
- 皮下脂肪组织VDR mRNA与脂肪组织胰岛素敏感性呈负相关(β=-0.207;P=0.025)。
临床怎么用
- 在超重/肥胖人群中,血浆维生素D代谢物水平不宜单独作为组织特异性胰岛素抵抗的循环标志物。
- 皮下脂肪组织VDR表达可能参与脂肪组织胰岛素敏感性的局部调控,但需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Vitamin D deficiency in obesity has been linked to insulin resistance. However, studies that examined the association between plasma 25-hydroxyvitamin D3 [25(OH)D3] as well as plasma 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] and tissue-specific insulin sensitivity are scarce. Furthermore, vitamin D receptor (VDR) and vitamin D-metabolizing enzymes [cytochrome 450 (CYP)] expression in adipose tissue (AT) might affect AT insulin sensitivity. OBJECTIVE: To investigate the association between body mass index (BMI) and plasma 25(OH)D3 and 1,25(OH)2D3, AT VDR; between plasma 25(OH)D3, 1,25(OH)2D3, AT VDR, and tissue-specific insulin sensitivity in individuals with overweight/obesity. DESIGN AND PATIENTS: This analysis included 92 adult individuals (BMI, >25 kg/m2). A two-step hyperinsulinemic-euglycemic clamp with a [6,6-2H2]-glucose tracer was performed to assess tissue-specific insulin sensitivity. Abdominal subcutaneous AT (SAT) mRNA expression of VDR and CYP was determined by using quantitative RT-PCR. SETTING: University medical center. MAIN OUTCOME MEASURES: Plasma 25(OH)D3, 1,25(OH)2D3, 1,25(OH)2D3/25(OH)D3 ratio, SAT VDR and CYPs mRNA, and tissue-specific insulin sensitivity. RESULTS: BMI was inversely associated with plasma 25(OH)D3 (β = -0.274; P = 0.011) but not with plasma 1,25(OH)2D3. Plasma 25(OH)D3 was not related to CYPs or VDR expression in SAT. Plasma 1,25(OH)2D3 and 25(OH)D3 were not related to tissue-specific insulin sensitivity. Interestingly, SAT VDR mRNA was negatively associated with AT insulin sensitivity (β = -0.207; P = 0.025). CONCLUSIONS: BMI was inversely associated with 25(OH)D3 concentrations, which could not be explained by alterations in SAT VDR and CYP enzymes. Plasma vitamin D metabolites were not related to tissue-specific insulin sensitivity. However, VDR expression in SAT was negatively associated with AT insulin sensitivity.
引用
- Pramono A, Jocken JWE, Essers YPG, et al. Vitamin D and Tissue-Specific Insulin Sensitivity in Humans With Overweight/Obesity. J Clin Endocrinol Metab. 2019. PMID: 30137362. doi:10.1210/jc.2018-00995
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。